{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nCirculating microRNA MIR6850-5p has been identified as a potential noninvasive prognostic biomarker in high‐grade serous ovarian carcinoma. Elevated levels of MIR6850-5p in patient serum were found to predict poorer progression‐free survival, suggesting that this miRNA may be implicated in the mechanisms that drive tumor aggressiveness and resistance to standard therapies. Given its stability in the bloodstream, MIR6850-5p could serve as an accessible marker for patient stratification and treatment monitoring in clinical settings, ultimately aiding in the earlier identification of patients at risk for adverse outcomes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Kosuke Yoshida, Akira Yokoi, Juntaro Matsuzaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.15154"}], "href": "https://doi.org/10.1111/cas.15154"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34618992"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34618992"}]}]}]}